News

Jul 12, 2017
Using several predicative factors for overall survival, researchers developed a risk score to help in selecting appropriate patients for transarterial chemoembolization. | Read More
Jul 07, 2017
The phase II, randomized trial compared combination treatment with systemic treatment alone in 119 patients with nonresectable colorectal liver metastases without extrahepatic disease. | Read More
Jun 26, 2017
Researchers conducted a retrospective study to assess the predictive abilities of the RENAL score compared with the mRENAL score. | Read More
Jun 21, 2017
Researchers examined resected tisssue from patients who underwent surgical resection 57, 79, 80, and 105 days after being treated with doxorubicin DEE chemoembolization. | Read More
Jun 15, 2017
Two types of antibiotic prophylaxis for embolotherapy were compared for patients who have undergone prior biliary procedures. | Read More
Jun 15, 2017
Researchers compared response rates and toxicity of segmental radioembolization and segmental chemoembolization for localized, unresectable hepatocellular carcinoma. | Read More
Jun 14, 2017
Researchers retrospectively reviewed data on more than 1,000 patients to determine whether taking medications such as aspirin, other NSAIDs, or beta blockers at the time as embolization improves survival rates. | Read More
May 22, 2017
The FOXFIRE, SIRFLOX and FOXFIRE-Global (FF-SF-FFG) randomized studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer (mCRC) with selective internal ra | Read More
May 22, 2017
Asian patients with locally advanced HCC without extra-hepatic metastasis treated with Y90 have statistically significant better TRR, and fewer SAEs | Read More
May 09, 2017
While SIRT demonstrated significantly reduced side effects, better quality of life, higher response rates and more effectively controlled tumor progression | Read More